Histoplasmosis

Essentials of Clinical Mycology: Second Edition

Volumn , Issue , 2011, Pages 321-335

  Kauffman, Carol A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867588170     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-6640-7_18     Document Type: Chapter

References (112)

1. Schwarz J. African histoplasmosis, part 2. In: Baker RD, editor. Human Infection with Fungi, Actinomycetes, and Algae. New York: Springer; 1970. p. 139-46.
2. Gabal MA, Hassan FK, Siad AA, Karim KA. Study of equine histoplasmosis farciminosi and characterization of Histoplasma farciminosum. Sabouraudia. 1983;21:121-7.
3. Ashbee HR, Evans EGV, Viviani MA, et al. Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Med Mycol. 2008;46:57-65.
4. Cano M, Hajjeh RA. The epidemiology of histoplasmosis: A review. Semin Respir Infect. 2001;16:109-18.
5. Schwarz J. Histoplasmosis. New York: Praeger Publishers; 1981.
6. Wheat LJ, Slama TG, Eitzen HE, Kohler RB, French MLV, Biesecker JL. A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med. 1981;94:331-7.
7. Sathapatayavongs B, Batteiger BE, Wheat J, Slama TG, Wass JL. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore). 1983;62:263-70.
8. Waldman RJ, England AC, Tauxe R, et al. A winter outbreak of acute histoplasmosis in northern Michigan. Am J Epidemiol. 1983;117:68-75.
9. Jones TF, Swinger GL, Craig AS, McNeil MM, Kaufman L, Schaffner W. Acute pulmonary histoplasmosis in bridge workers: A persistent problem. Am J Med. 1999;106:480-2.
10. Sacks JJ, Ajello L, Crockett LK. An outbreak and review of caveassociated Histoplasmosis capsulati. J Med Vet Mycol. 1986;24: 313-27.
11. Brodsky AL, Gregg MB, Kaufman L, Mallison GF. Outbreak of histoplasmosis associated with the 1970 Earth Day activities. Am J Med. 1973;54:333-42.
12. Dupont B, Crewe Brown HH, et al. Mycoses in AIDS. Med Mycol. 2000;38 Suppl 1:259-67.
13. Mata-Essayag S, Colella MT, Rosello A, et al. Histoplasmosis. a study of 158 cases in Venezuela, 2000-2005. Medicine (Baltimore). 2008;87:193-202.
14. Baddley JW, Sankara IR, Rodriquez JM, Pappas PG, Wickliffe Jr. JM. Histoplasmosis in HIV-infected patients in a southern regional medical center: Poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis. 2008;62:151-6.
15. Kauffman CA. Endemic mycoses after hematopoietic stem cell or solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV, editors. Transplant Infections. 2nd ed. Lippincott: Williams & Wilkins; 2003. p. 524-34.
16. Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumor necrosis factor-alpha inhibitor therapy. Drugs. 2009;69(11):1403-15.
17. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor-alpha blockade therapy. Mayo Clin Proc. 2008;83:181-94.
18. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis. 2005;7:109-15.
19. Gugnani HC, Muotoe-Okafar FA, Kaufman L, Dupont B. Natural focus of Histoplasma capsulatum var. duboisii in a bat cave. Mycopathologia. 1994;127:151-7.
20. Loulergue P, Bastides F, Baudouin V, et al. Literature review and case history of Histoplasma capsulatum var. duboisii infections in HIV-infected patients. Emerg Infect Dis. 2007;13:1647-52.
21. Manfredi R, Mazzoni A, Nanetti A, Chiodo F. Histoplasmosis capsulati and duboisii in Europe: The impact of the HIV pandemic, travel, and immigration. Eur J Epidemiol. 1994;10:675-81.
22. Bullock WE, Wright SD. Role of the adherence-promoting receptors, CR3, LFA-1, and p150, 95 in binding of H. capsulatum by human macrophages. J Exp Med. 1987;165:195-210.
23. Eissenberg LG, Goldman WE, Schlesinger PH. Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med. 1993;177:1605-11.
24. Newman SL. Cell-mediated immunity to Histoplasma capsulatum. Semin Respir Infect. 2001;16:102-8.
25. Woods JP, Heinecke EL, Luecke JW, et al. Pathogenesis of Histoplasma capsulatum. Semin Respir Infect. 2001;16:91-101.
26. Deepe Jr. GS. Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells. Infect Immun. 1988;56:2350-5.
27. Deepe Jr. GS, Gibbons RS. T cells require tumor necrosis factor- Alpha to provide protective immunity in mice infected with Histoplasma capsulatum. J Infect Dis. 2006;193:322-30.
28. Deepe Jr. GS, McGuinness M. Interleukin-1 and host control of pulmonary histoplasmosis. J Infect Dis. 2006;194:855-64.
29. McKinsey DS, Spiegel RA, Hutwanger L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: Incidence, risk factors, and pathophysiology. Clin Infect Dis. 1997;24:1195-203.
30. Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2005;41:38-41.
31. Kauffman CA, Israel KS, Smith JW, White AC, Schwarz J, Brooks GF. Histoplasmosis in immunosuppressed patients. Am J Med. 1978;64:923-32.
32. Hajjeh RA. Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995;21 Suppl 1:S108-10.
33. Dean AG, Bates JH, Sorrels C, et al. An outbreak of histoplasmosis at an Arkansas courthouse, with five cases of probable reinfection. Am J Epidemiol. 1978;108:36-46.
34. Ozols II, Wheat LJ. Erythema nodosum in an epidemic of histoplasmosis in Indianapolis. Arch Dermatol. 1981;117:709-12.
35. Rosenthal J, Brandt KD, Wheat LJ, Slama TG. Rheumatologic manifestations of histoplasmosis in the recent Indianapolis epidemic. Arthritis Rheum. 1983;26:1065-70.
36. Goodwin RA, Loyd JE, Des Prez RM. Histoplasmosis in normal hosts. Medicine (Baltimore). 1981;60:231-66.
37. Hage CA, Wheat JL, Loyd J, Allen SD, Blue D, Knox KS. Pulmonary histoplasmosis. Semin Respir Crit Care Med. 2008;29:151-65.
38. Gurney JW, Conces DJ. Pulmonary histoplasmosis. Radiology. 1996;199:297-306.
39. Goodwin Jr. RA, Owens FT, Snell JD, et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore). 1976;55:413-52.
40. Wheat LJ, Wass J, Norton J, Kohler RB, French MLV. Cavitary histoplasmosis occurring during two large urban outbreaks: Analysis of clinical, epidemiologic, roentgenograghic, and laboratory features. Medicine (Baltimore). 1984;63:201-9.
41. Furcolow ML. Comparison of treated and untreated severe histoplasmosis. J Am Med Assoc. 1963;183:121-7.
42. Parker JD, Sarosi GA, Doto IL, Bailey RE, Tosh FE. Treatment of chronic pulmonary histoplasmosis. N Engl J Med. 1970;283:225-9.
43. Kennedy CC, Limper AH. Redefining the clinical spectrum of chronic pulmonary histoplasmosis. A retrospective case series of 46 patients. Medicine (Baltimore). 2007;86:252-8.
44. Parish JM, Rosenow EC. Mediastinal granuloma and mediastinal fibrosis. Semin Respir Crit Care Med. 2002;23:135-43.
45. Davis AM, Pierson RN, Loyd JE. Mediastinal fibrosis. Semin Respir Infect. 2001;16:119-30.
46. Goodwin RA, Nickell JA, des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore). 1972;51:227-46.
47. Loyd JE, Tillman BF, Atkinson JB, Des Prez RM. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore). 1988;67:295-310.
48. Conces DJ, Tarver RD, Viz VA. Broncholithiasis: CT features in 15 patients. Am J Roentgenol. 1991;157:249-53.
49. Picardi JL, Kauffman CA, Schwarz J, Holmes JC, Phair JP, Fowler NO. Pericarditis caused by Histoplasma capsulatum. Am J Cardiol. 1976;37:82-8.
50. Wheat LJ, Stein L, Corya BC, et al. Pericarditis as a manifestation of histoplasmosis during two large urban outbreaks. Medicine (Baltimore). 1983;62:110-9.
51. Goodwin Jr. RA, Shapiro JL, Thurman GH, Thurman SS, des Prez RM. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore). 1980;59:1-33.
52. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore). 1990;69:361-74.
53. Odio CM, Navarrete M, Carrillo JM, Mora L, Carranza A. Disseminated histoplasmosis in infants. Pediatr Infect Dis J. 1999;18:1065-8.
54. Davies SF, Khan M, Sarosi GA. Disseminated histoplasmosis in immunologically suppressed patients. Am J Med. 1978;64:94-100.
55. Koduri PR, Chundi V, DeMarais P, Mizock BA, Patel AR, Weinstein RA. Reactive hemophagocytic syndrome: A new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis. 1995;21:1453-5.
56. Sanchez A, Celaya AK, Victorio A. Histoplasmosis-associated hemophagocytic syndrome: A case report. AIDS Read. 2007;17: 496-502.
57. Smith JW, Utz JP. Progressive disseminated histoplasmosis: A prospective study of 26 patients. Ann Intern Med. 1972;76:557-65.
58. Wilson DA, Muchmore HG, Tisda RG, Fahmy A, Pitha JV. Histoplasmosis of the adrenal glands studied by CT. Radiology. 1984;150:779-83.
59. Gulati M, Saint S, Tierney LM. Clinical problem-solving. Impatient inpatient care. N Engl J Med. 2000;342:37-40.
60. Gaynes RP, Gardner P, Causey W. Prosthetic value endocarditis caused by Histoplasma capsulatum. Arch Intern Med. 1981;141:1533-7.
61. Bradsher RW, Wickre CG, Savage AM, Harston WE, Alford RH. Histoplasma capsulatum endocarditis cured by amphotericin B combined with surgery. Chest. 1980;78:791-5.
62. Rogers EW, Weyman AE, Noble RJ, Bruins SC. Left artial myxoma infected with Histoplasma capsulatum. Am J Med. 1978;64:683-90.
63. Matthay RA, Levin DC, Wicks AB, Ellis JH. Disseminated histoplasmosis involving an aortofemoral prosthetic graft. J Am Med Assoc. 1976;235:1478-9.
64. Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system: A clinical review. Medicine (Baltimore). 1990;69:244-60.
65. Wheat LJ, Musial CE, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis. 2005;40:844-52.
66. Klein CJ, Dinapoli RB, Temesgen Z, Meyer FB. Central nervous system histoplasmosis mimicking a brain tumor: difficulties in diagnosis and treatment. Mayo Clin Proc. 1999;74:803-7.
67. Darouiche RO, Cadle RM, Zenon GJ, Weinert MF, Hamill RJ, Lidsky MD. Articular histoplasmosis. J Rheumatol. 1992;19:1991-3.
68. Fowler Jr. VG, Nacinovich FM, Alspaugh JA, Corey GR. Prosthetic joint infection due to Histoplasma capsulatum: case report and review. Clin Infect Dis. 1998;26:1017.
69. Lamps LW, Molina CP, West AB, Haggitt RC, Scott MA. The pathologic spectrum of gastrointestinal and hepatic histoplasmosis. Am J Clin Pathol. 2000;113:64-72.
70. Suh KN, Anekthananon T, Mariuz PR. Gastrointestinal histoplasmosis in patients with AIDS: case report and review. Clin Infect Dis. 2001;32:483-91.
71. Kauffman CA, Slama TG, Wheat LJ. Histoplasma capsulatum epididymitis. J Urol. 1981;125:434-5.
72. Schuster TG, Hollenbeck BK, Kauffman CA, Chensue SW, Wei JT. Testicular histoplasmosis. J Urol. 2000;164:1652.
73. Mawhorter SD, Curley GV, Kursh ED, Farver CE. Prostatic and central nervous system histoplasmosis in an immunocompetent host: case report and review of the prostatic histoplasmosis literature. Clin Infect Dis. 2000;30:595-8.
74. Whitt SP, Koch GA, Fender B, Ratnasamy N, Everett D. Histoplasmosis in pregnancy: case series and report of transplacental transmission. Arch Intern Med. 2004;164:454-8.
75. Oliver A, Ciulla TA, Comer GM. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment. Curr Opin Ophthalmol. 2005;16:160-5.
76. Suttorp-Schulten MSA, Bollemeijer JG, Bos PJM, Rothova A. Presumed ocular histoplasmosis in the Netherlands - An area without histoplasmosis. Br J Ophthalmol. 1997;81:7-11.
77. Specht CS, Mitchell KT, Bauman AE, Gupta M. Ocular histoplasmosis with retinitis in a patient with acquired immune deficiency syndrome. Ophthalmology. 1991;98:1356-9.
78. Wilson ML, Davis TE, Mirrett S, et al. Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J Clin Microbiol. 1993;31:865-71.
79. Smith CD, Goodman L. Improved culture method for the isolation of Histoplasma capsulatum and Blastomyces dermatitidis from contaminated specimens. Am J Clin Pathol. 1975;63:276-80.
80. Stockman L, Clark KA, Hunt JM, Roberts GD. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol. 1993;31:845-50.
81. Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med. 1986;314:83-8.
82. Wheat LJ. Improvements in diagnosis of histoplasmosis. Expert Opin Biol Ther. 2006;6:1207-21.
83. Connolly PA, Durkin MM, LeMonte AM, Hackett EJ, Wheat LJ. Detection of Histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol. 2007;14:1587-91.
84. Swartzentruber S, Rhodes L, Kurkjian K, et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis. 2009;49(6):928-30.
85. Wheat LJ, Connolly-Stringfield P, Williams B, et al. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis. 1992;145:1421-4.
86. Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis. 1997;24:1169-71.
87. Kuberski T, Myers R, Wheat LJ, Kubak BM, Bruckner D, Pegues D. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin Infect Dis. 2007;44:e50-4.
88. Durkin M, Witt J, LeMonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol. 2004;42:4873-5.
89. Martagon-Villamil J, Shrestha N, Sholtis M, et al. Identification of Histoplasma capsulatum from culture extracts by real-time PCR. J Clin Microbiol. 2003;41:1295-8.
90. Bialek R, Ernst F, Dietz K, et al. Comparison of staining methods and a nested PCR assay to detect Histoplasma capsulatum in tissue sections. Am J Clin Pathol. 2002;117:597-603.
91. Bracca A, Tosello ME, Girardini JE, Amigot SL, Gomez C, Serra E. Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples. J Clin Microbiol. 2003;41:1753-5.
92. Rickerts V, Bialek R, Tintelnot K, Jacobi V, Just-Nubling G. Rapid PCR-based diagnosis of disseminated histoplasmosis in an AIDS patient. Eur J Clin Microbiol Infect Dis. 2002;21:821-3.
93. Picardi JL, Kauffman CA, Schwarz J, Phair JP. Detection of precipitating antibodies to Histoplasma capsulatum by counterimmunoelectrophoresis. Am Rev Respir Dis. 1976;114:171-6.
94. Wheat LJ, Freifeld AG, Kleiman MG, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807-27.
95. Dismukes WE, Bradsher Jr. RW, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med. 1992;93:489-97.
96. McKinsey DS, Kauffman CA, Pappas PG, et al. Fluconazole therapy for histoplasmosis. Clin Infect Dis. 1996;23:996-1001.
97. Doyle TP, Loyd JE, Robbins IM. Percutaneous pulmonary artery and vein stenting: A novel treatment for mediastinal fibrosis. Am J Respir Crit Care Med. 2001;164:657-60.
98. Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med. 2002;137:105-9.
99. Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med. 1995;98:336-42.
100. Wheat J, MaWhinney S, Hafner R, et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med. 1997;103:223-32.
101. Pitisuttithum P, Negroni R, Graybill JR, et al. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother. 2005;6:745-55.
102. Restrepo A, Tobon A, Clark B, et al. Salvage treatment of histoplasmosis with posaconazole. J Infect. 2007;54:319-27.
103. Freifeld A, Proia L, Andes D, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother. 2009;53:1648-51.
104. Wheat J, Hafner R, Wulfson M, et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1993;118:610-6.
105. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis. 2004;38:1485-9.
106. Bamberger DM. Successful treatment of multiple cerebral histoplasmomas with itraconazole. Clin Infect Dis. 1999;28:915-6.
107. Schestatsky P, Chedid MF, Amaral OB, Unis G, Oliveira FM, Severo LC. Isolated central nervous system histoplasmosis in immunocompetent hosts: A series of 11 cases. Scand J Infect Dis. 2006;38:43-8.
108. Tiraboschi I, Casas Parera I, Pikielny R, Scattini G, Micheli F. Chronic Histoplasma capsulatum infection of the central nervous system successfully treated with fluconazole. Eur Neurol. 1992;32:70-3.
109. Lortholary O, Denning DW, Dupont B. Endemic mycoses: A treatment update. J Antimicrob Chemother. 1999;43:321-31.
110. Lenhart SW, Schafer MP, Singal M, Hajjeh RA. Histoplasmosis: Protecting Workers at Risk. Cincinnati: US Department of Health and Human Services; 1997.
111. McKinsey DS, Wheat LJ, Cloud GA, et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. Clin Infect Dis. 1999;28:1049-56.
112. Edwards LB, Acquaviva SA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. 1969;99:1-18.